Back to Search
Start Over
A difficult situation – balancing critical anticoagulation versus the risk of permanent neurologic deficit: a case report
- Source :
- Journal of Medical Case Reports, Vol 12, Iss 1, Pp 1-6 (2018), Journal of Medical Case Reports
- Publication Year :
- 2018
- Publisher :
- Springer Science and Business Media LLC, 2018.
-
Abstract
- Background Anticoagulation is the mainstay of treatment for pulmonary embolism. However, if bleeding unfortunately occurs, the risks and benefits of anticoagulation present a challenge. Management of one hemorrhagic complication, retroperitoneal hematoma, is rare, difficult, and controversial. Case presentation A 73-year-old white man presented with left lower extremity swelling and dyspnea. He was tachycardic, hypertensive, and demonstrated poor oxygen saturation of 81% on ambient air. A computed tomography angiogram revealed a saddle pulmonary embolus. Tissue plasminogen activator was administered and he was started on a heparin infusion. He was eventually transitioned to enoxaparin. On the day of discharge, however, he had sudden onset of right leg numbness and weakness below his hip. A computed tomography of his head was not concerning for stroke, and neurology was consulted. Neurology was concerned for spinal cord infarction versus hematoma and recommended magnetic resonance imaging of his thoracic and lumbar spine. The magnetic resonance imaging revealed a left psoas hematoma. A computed tomography scan of his pelvis also showed a right psoas and iliacus hematoma. He was transitioned to a low intensity heparin infusion. The following day his left leg exhibited similar symptoms. There was concern of progressive and irreversible nerve damage due to compression if the hematomas were not drained. Interventional radiology was consulted for drainage. The heparin infusion was paused, drainage was performed, and the heparin infusion was reinitiated 6 hours following the procedure by interventional radiology. His blood counts and neurologic examination stabilized and eventually improved. He was discharged home on a novel anticoagulant. Conclusions Management of a retroperitoneal hematoma can commence with recognition of the warning signs of bleeding and neurological impairment, and consulting the appropriate services in case the need for intervention arises. A conservative approach of volume resuscitation and blood transfusion can be used initially, with the need for pausing or reversing anticoagulation being assessed on an individual basis with expert consultation. If intervention becomes necessary, other interventional radiology-based modalities can be used to identify and stop the bleeding source, and interventional radiology-guided drainage can be performed to decrease the hematoma burden and relieve neurological symptoms.
- Subjects :
- Male
Resuscitation
medicine.medical_specialty
Neurology
medicine.drug_class
lcsh:Medicine
Case Report
030204 cardiovascular system & hematology
Anticoagulation
03 medical and health sciences
0302 clinical medicine
Hematoma
Neurologic deficit
medicine
Humans
Thrombolytic Therapy
Enoxaparin
Stroke
Aged
medicine.diagnostic_test
Heparin
business.industry
Pulmonary embolism
lcsh:R
Anticoagulant
Anticoagulants
Interventional radiology
Magnetic resonance imaging
General Medicine
medicine.disease
Surgery
Retroperitoneal hematoma
Tissue Plasminogen Activator
030220 oncology & carcinogenesis
Nervous System Diseases
business
Subjects
Details
- ISSN :
- 17521947
- Volume :
- 12
- Database :
- OpenAIRE
- Journal :
- Journal of Medical Case Reports
- Accession number :
- edsair.doi.dedup.....82f1f6b5e52af0efc533313d70ebd11c